Please assess the completion status of the following clinical trial:

Trial Title: Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female ≥ \[greater than or equal to\] 40 years of age~* If a participant in the previous DIC3-08-05 study, completed the study and did not discontinue for lack of efficacy or safety~* Has a diagnosis of OA of the hip or knee with ongoing knee and/or articular hip pain~* Is a current chronic user of nonsteroidal anti-inflammatory drugs (NSAIDs) and/or acetaminophen for his/her OA pain and is anticipated to benefit from continuous treatment with therapeutic doses of NSAIDs. A current chronic user is defined as a subject who has used these treatments for ≥ \[greater than or equal to\] 20 days of the last 30 days before screening~Exclusion Criteria:~* Has a known history of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any nonsteroid anti-inflammatory drugs (NSAIDs), including diclofenac~* Requires chronic use of opioid or opioid combination products to control OA pain of the knee or hip~* Has any clinically significant unstable cardiac, respiratory, neurological, immunological, hematological, or renal disease~* Has significant difficulties swallowing capsules or is unable to tolerate oral medication

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diclofenac Capsules 35 mg bid or tid (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).